Publication | Closed Access

Comparison of glatiramer acetate (Copaxone®) and interferon β-1b (Betaferon®) in multiple sclerosis patients: an open-label 2-year follow-up

Multiple Sclerosis PatientsNeurobiology Of DiseaseNeurological DisorderImmunologyClinical TrialsBrain-immune InteractionNeurologyMultiple SclerosisMedicineInterferon β-1BNeuroimmunologyGlatiramer Acetate